The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with recurrent gynaecological cancer and peritoneal carcinomatosis.
Marc A Reymond
Consultant or Advisory Role - Reger Medizintechnik GmbH
Wiebke Solass
No relevant relationships to disclose
Urs Giger-Pabst
No relevant relationships to disclose
Dirk Strumberg
No relevant relationships to disclose
Jurgen Zieren
No relevant relationships to disclose
Clemens Tempfer
No relevant relationships to disclose